News & Insights
The latest from Keningford Partners.
Perspectives on capital markets, transactions, and firm developments - drawn from live mandate activity across equity, debt, and M&A.
Keningford Partners publishes in-depth perspectives on the trends shaping how growth-stage companies raise capital and transact. Our coverage draws on activity across the sectors we advise - equity, debt, and strategic M&A - so founders, boards, and investors can see where capital is moving, not just where headlines point. For institutional and professional use only.
The Latest
News & market notes
Current Mandate
Advising EnergyCite on Its Current Capital Raise
Keningford Partners is advising EnergyCite on its current capital raise. Founded by the inventor of the smart utility meter, EnergyCite is commercializing an AI-powered conservation app that gives residential customers real-time visibility into usage, rates, and monthly spend.
- Seven granted patents on smart metering and in…
- AI conservation app with real-time kWh usage, …
- Recurring-revenue licensing model targeting 10…
Current Mandate
Advising EcoPha Biotech on Its Current Capital Raise
Keningford Partners is advising EcoPha Biotech on its current capital raise. The company is developing sustainable bioplastics and aviation fuel from a single non-edible feedstock - a dual-output platform anchored by a Queensland flagship project with government co-funding and strategic partnerships across aviation and industrial sectors.
Vertical AI Capital Trajectory: What H2 2026 Looks Like for Growth Rounds
Vertical AI has become one of the most contested growth-stage capital destinations. Investors are paying for workflow depth, retention, and defensible data - not model wrappers.
Healthcare AI Equity: What Growth-Stage Round Data Actually Shows
Healthcare AI rounds in 2025–2026 closed at premium multiples relative to horizontal software - but only for assets with reimbursement clarity, clinical validation, and enterprise distribution.
Family Office Allocation Shift: H2 2026 Watch
Family offices are redeploying toward direct investments, co-investments, and structured equity - with longer hold periods and sharper governance expectations than the prior cycle.
The Debt-First Capital Stack: A Founder's Toolkit
When equity is expensive, growth-stage founders are rebuilding the capital stack with venture debt, structured credit, and hybrid instruments, without defaulting to dilution.
Founder Liquidity Without IPO: Secondary Tender Structures
As the median time from Series A to IPO stretches past a decade, secondary tenders and structured liquidity programs have become a core tool for retention - not a sign of weakness.
The Down-Round Playbook: Structural Options for Founders in 2026
Down rounds are no longer exceptional. Founders facing a reset should compare four structural paths - and three questions - before signing terms.
Q2 2026 Lower Middle Market Capital Outlook
Credit conditions, equity selectivity, and process length are reshaping how lower middle-market companies access institutional capital in the second half of 2026.
The 14-Week Growth-Round Cycle: What Changed for Founders
Institutional growth equity processes have lengthened. Founders should treat fourteen weeks as the operational base case, and prepare runway accordingly.
Capital Markets Outlook for 2026
After two years of repricing across rates, credit spreads, and equity multiples, issuers and sponsors are entering 2026 with clearer visibility, but capital providers are demanding more on quality, governance, and use of proceeds.
Keningford Partners Launches as Boutique Capital Advisory and M&A Firm in New York
Keningford Partners has officially launched in New York, led by Founder and Managing Partner Tuna Yilar, with a principal-led model focused on capital raises, M&A advisory, and debt advisory from Series A through pre-IPO.
Keningford Partners Advises on $150 Million Growth Equity Financing
Keningford Partners served as exclusive financial advisor to a vertical software platform in a $150 million growth equity round led by a North American institutional syndicate.
Strategic M&A Activity Accelerates in Healthcare Services
Deal volume in outpatient, behavioral health, and physician services remains elevated, but valuation dispersion between market leaders and the broader field has rarely been wider.
Keningford Partners Expands Senior Advisory Team
The firm has appointed three Managing Directors across M&A, capital raising, and restructuring advisory, extending senior coverage in technology, healthcare, and industrials.